The Purification & Filtration division manufactures filters and membranes for biopharmaceutical and medical technologies, microelectronics, food and beverage goods, and drinking water. It employs over 2,500 people worldwide and has locations in the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Solventum’s Purification & Filtration division is expected to earn almost $1 billion in revenue by 2024.
Marc Casper, chairman, president and CEO of Thermo Fisher, said: “As the trusted partner to our customers, Solventum’s Purification & Filtration business will expand and add differentiated capabilities to our bioprocessing portfolio to better serve our customers in this rapidly growing market. We look forward to welcoming our new colleagues to Thermo Fisher.”
The acquisition is scheduled to close by the end of 2025, subject to regulatory approval and usual closing conditions.
Following the transaction, Thermo Fisher’s Life Sciences Solutions sector will include the Purification & Filtration business.
